Literature DB >> 26319348

Glaucoma.

Anand V Mantravadi1, Neil Vadhar2.   

Abstract

Glaucoma is a multifactorial degenerative optic neuropathy that can progress at variable rates and afflict all age groups. It is the second leading cause of blindness worldwide. The disease is commonly divided into 2 major subtypes, open angle and angle closure. Diagnosis of glaucoma is made by a combination of identifying characteristic changes of the optic nerve, functional testing such as visual fields, and structural imaging of the optic nerve. Management is aimed at reducing intraocular pressure (IOP). Patients with known risk factors should be referred to an ophthalmologist for complete evaluation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angle closure; Diagnosis; Glaucoma; Management; Open angle; Referral; Screening

Mesh:

Substances:

Year:  2015        PMID: 26319348     DOI: 10.1016/j.pop.2015.05.008

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  37 in total

1.  Non-Synonymous variants in premelanosome protein (PMEL) cause ocular pigment dispersion and pigmentary glaucoma.

Authors:  Adrian A Lahola-Chomiak; Tim Footz; Kim Nguyen-Phuoc; Gavin J Neil; Baojian Fan; Keri F Allen; David S Greenfield; Richard K Parrish; Kevin Linkroum; Louis R Pasquale; Ralf M Leonhardt; Robert Ritch; Shari Javadiyan; Jamie E Craig; W T Allison; Ordan J Lehmann; Michael A Walter; Janey L Wiggs
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

Review 2.  Regulation of Cell Behavior by Hydrostatic Pressure.

Authors:  Shaobao Liu; Ru Tao; Ming Wang; Jin Tian; Guy M Genin; Tian Jian Lu; Feng Xu
Journal:  Appl Mech Rev       Date:  2019-07-23       Impact factor: 7.281

3.  Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma.

Authors:  S Daniel; K J Meyer; A F Clark; M G Anderson; C M McDowell
Journal:  Exp Eye Res       Date:  2019-06-15       Impact factor: 3.467

Review 4.  Pupillary response to chromatic light stimuli as a possible biomarker at the early stage of glaucoma: a review.

Authors:  Carla Arévalo-López; Silvia Gleitze; Samuel Madariaga; Iván Plaza-Rosales
Journal:  Int Ophthalmol       Date:  2022-07-04       Impact factor: 2.031

Review 5.  A Review on Glaucoma Drainage Devices and its Complications.

Authors:  Sajal Gupta; Sandhya Jeria
Journal:  Cureus       Date:  2022-09-12

Review 6.  The role of microglia in the progression of glaucomatous neurodegeneration- a review.

Authors:  Hui-Lan Zeng; Jing-Ming Shi
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

Review 7.  Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma.

Authors:  Sanaz Behtaj; Andreas Öchsner; Yuri G Anissimov; Maksym Rybachuk
Journal:  Tissue Eng Regen Med       Date:  2020-05-10       Impact factor: 4.169

8.  Potentially inappropriate prescriptions of anticholinergic medications in patients with closed-angle glaucoma.

Authors:  Luis Fernando Valladales-Restrepo; Jorge Enrique Machado-Alba
Journal:  Int Ophthalmol       Date:  2019-12-03       Impact factor: 2.031

9.  Altered functional connectivity density in primary angle-closure glaucoma patients at resting-state.

Authors:  Linglong Chen; Shenghong Li; Fengqin Cai; Lin Wu; Honghan Gong; Chonggang Pei; Fuqing Zhou; Xianjun Zeng
Journal:  Quant Imaging Med Surg       Date:  2019-04

Review 10.  Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors.

Authors:  R Brito; K C Calaza; D Pereira-Figueiredo; A A Nascimento; M C Cunha-Rodrigues
Journal:  Cell Mol Neurobiol       Date:  2021-03-17       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.